Response by Figtree et al to Letter Regarding Article, "Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)".
Response by Figtree et al to Letter Regarding Article, "Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)".
Circulation. 2019 Jan 15;139(3):418-419
Authors: Figtree GA, Rådholm K, Neal B
PMID: 30640545 [PubMed - in process]
Source: Circulation - Category: Cardiology Authors: Figtree GA, Rådholm K, Neal B Tags: Circulation Source Type: research
More News: Canagliflozin | Cardiology | Cardiovascular | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Heart | Heart Failure | Invokana | Study